| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |